Kerr Douglas bought DYN
October 20, 2026 · Form 4 insider transaction
Kerr Douglas bought 8,000 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$0.00
Total value
N/A
InsiderKerr Douglas
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 20, 2026
Filing dateOctober 22, 2026
Shares owned after170,564
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of shares of Common Stock issuable under 8,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on January 20, 2027.; Includes 133,126 unvested RSUs.